


Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms
Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms Autophagy, Protein Phosphatase 2A, Myeloproliferative neoplasms. Carine Joffre and Véronique De-Mas team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia The...
CD36 drives metastasis and relapse in acute myeloid leukemia
CD36 drives metastasis and relapse in acute myeloid leukemia Acute myeloid leukemia, metastasis, CD36, relapse. Thomas Farge , Jean Nakhle audrey Carrière-Pazat Team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemiaet METABOLINK of Restore...
A computational model of the formation of cells limiting the effect of promising cancer therapies
A computational model of the formation of cells limiting the effect of promising cancer therapies Cancer, Computational bioinformatics, systems biology; Health sciences; Immunology mathematical models for health. Véra Pancaldi Team NetB(IO)² : Network Biology for...
Cancer under pressure: which signals are activated?
Cancer under pressure: which signals are activated? mechanical forces, cancer, mechanosensing, compression, confinement, targeted therapies, cell signaling. Julie Guillermet-Guibert Team SigDyn Integrated cellular signalling and PI3K isoforms In living organisms,...